Author + information
O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:485–510, http://dx.doi.org/10.1016/j.jacc.2012.11.018.
In Section 8.1 (page 498), the following recommendation was incorrectly listed as Class IIa and should be changed to Class IIb:
1. Alternative left ventricular (LV) assist devices for circulatory support may be considered in patients with refractory cardiogenic shock. (Level of Evidence: C)
In Section 8.5 (page 498), the following recommendations were incorrectly listed as Class IIa and should be changed to Class IIb:
1. Anticoagulant therapy may be considered for patients with STEMI and anterior apical akinesis or dyskinesis. (Level of Evidence: C)
2. Targeting vitamin K antagonist therapy to a lower international normalized ratio (e.g., 2.0 to 2.5) might be considered in patients with STEMI who are receiving DAPT. (Level of Evidence: C)
- American College of Cardiology Foundation